New acne cream trial seeks clearer skin for hundreds

NCT ID NCT07186413

Summary

This study is testing whether a cream called trifarotene works better than a placebo cream to treat moderate acne on the face and body. About 561 Chinese participants aged 9 and older will apply the cream once daily for 12 weeks. Researchers will measure changes in acne severity and count pimples to see if the treatment is effective and safe.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Galderma Research & Development Site #5378

    RECRUITING

    Shanghai, Jing'an District, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.